XML 65 R48.htm IDEA: XBRL DOCUMENT
v3.20.4

Quarterly Information (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract] |
Schedule of Quarterly Financial Information | The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2020 and 2019.
|  | Quarter Ended |  |
|  | March 31, |  |  | June 30, |  |  | September 30, |  |  | December 31, |  |
|  | (In thousands except per share amounts) |  |
2020: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 509,217 |  |  | $ | 491,475 |  |  | $ | 547,961 |  |  | $ | 541,276 |  |
Income from continuing operations, net of taxes |  | $ | 21,251 |  |  | $ | 30,721 |  |  | $ | 45,063 |  |  | $ | 46,156 |  |
Income (loss) from discontinued operations, net of taxes |  | $ | 12,816 |  |  | $ | 10,993 |  |  | $ | (7,502 | ) |  | $ | (828,697 | ) | (1)
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 33,463 |  |  | $ | 41,079 |  |  | $ | 36,998 |  |  | $ | (783,672 | ) | (1)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.24 |  |  | $ | 0.34 |  |  | $ | 0.51 |  |  | $ | 0.51 |  |
Income (loss) from discontinued operations |  | $ | 0.14 |  |  | $ | 0.13 |  |  | $ | (0.09 | ) |  | $ | (9.42 | ) | (1)
Net (loss) income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.38 |  |  | $ | 0.47 |  |  | $ | 0.42 |  |  | $ | (8.91 | ) | (1)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.23 |  |  | $ | 0.34 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |
Income (loss) from discontinued operations |  | $ | 0.15 |  |  | $ | 0.12 |  |  | $ | (0.08 | ) |  | $ | (9.28 | ) | (1)
Net (loss) income attributable to Acadia Healthcare Company, Inc. |  | $ | 0.38 |  |  | $ | 0.46 |  |  | $ | 0.42 |  |  | $ | (8.78 | ) | (1)
2019: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 487,960 |  |  | $ | 509,813 |  |  | $ | 509,383 |  |  | $ | 501,225 |  |
Income (loss) from continuing operations, net of taxes |  | $ | 13,618 |  |  | $ | 26,964 |  |  | $ | 24,920 |  |  | $ | (12,192 | ) | (2)
Income from discontinued operations, net of taxes |  | $ | 15,893 |  |  | $ | 21,237 |  |  | $ | 17,803 |  |  | $ | 1,879 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 29,471 |  |  | $ | 48,140 |  |  | $ | 42,566 |  |  | $ | (11,254 | ) | (2)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.16 |  |  | $ | 0.31 |  |  | $ | 0.28 |  |  | $ | (0.15 | ) | (2)
Income from discontinued operations |  | $ | 0.18 |  |  | $ | 0.24 |  |  | $ | 0.21 |  |  | $ | 0.02 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.49 |  |  | $ | (0.13 | ) | (2)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc. |  | $ | 0.15 |  |  | $ | 0.31 |  |  | $ | 0.28 |  |  | $ | (0.15 | ) | (2)
Income from discontinued operations |  | $ | 0.19 |  |  | $ | 0.24 |  |  | $ | 0.20 |  |  | $ | 0.02 |  | (2)
Net income (loss) attributable to Acadia Healthcare Company, Inc. |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.48 |  |  | $ | (0.13 | ) | (2)
(1) | Includes U.K. loss on sale of $867.3 million which includes approximately $356.2 million of non-cash goodwill impairment.
(2) | Includes loss on impairment of $27.2 million in continuing operations and $27.2 million in discontinued operations.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration